This multidisciplinary team brings together physicists, electronics engineers, computer scientists, chemists, and doctors to develop new diagnostic and therapeutic means using nanotechnologies, the Internet of Things (IoT) and artificial intelligence (AI).

From nanoparticles to nanovectors, nanomedicine makes it possible to intervene at the level of the cells themselves, a rare and promising prospect for the treatment of certain rare diseases and cancers. The team is interested in liver cancer, Alzheimer’s disease and Sars-Cov2. It uses functionalized nanoparticles to better target both diagnosis and better treatment. The use of natural functions chemically grafted onto their surface allows us to identify diseased cells, while the intrinsic properties of the nanoparticle allow us to destroy them or deliver drugs. These drugs can be known or completely constructed (drug design) to be active using our molecular simulation tools. Molecular docking, coupled with AI, gives us a range of molecular targets to consider in the fight against previously intractable diseases.

The Internet of Things (IoT) is a multi-use tool that is mainly used in the laboratory to detect using sensor networks. Several projects are based on our tools and have made it possible to set up demonstrators, currently in the testing phase, for the control and prevention of falls in the elderly. Other projects, coupling IoT and AI, are actively developed within the team.

Finally, the transversal AI axis is at the heart of the concerns of team 3. Our researchers use and develop AI tools in order to organize health systems in different sectors including hospital emergencies, public or private, hospital services or even SAMU.